Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Medical Oncology
Published in: Medical Oncology 4/2008

01-12-2008 | Original Paper

Choroidal mass as an initial presentation of lung cancer

Authors: Tulay Simsek, Yasemin Ozdamar, Nilufer Berker

Published in: Medical Oncology | Issue 4/2008

Login to get access

Abstract

Choroidal mass may be a presenting sign of systemic malignancy. The diagnosis of metastatic ocular tumor is important because it can indicate poor prognosis. We report a case of a 45-year-old man presenting to our clinic with the complaint of decreased vision in the left eye, which is the initial finding of non-small cell lung-carcinoma.
Literature
1.
Goldberg RA, Rootman J, Cline RA. Tumors metastatic to the orbit: a changing picture. Surv Ophthalmol 1990;35:1–24.PubMedCrossRef
2.
Shields CL, Shields JA, Gross NE, Schwartz GP, Lally SE. Survey of 520 eyes with uveal metastases. Ophthalmology 1997;104:1265–76.PubMed
3.
Kreusel KM, et al. Choroidal metastasis in disseminated lung cancer: frequency and risk factors. Am J Ophthalmol 2002;134:445–7.PubMedCrossRef
4.
5.
Char DH. Posterior uveal tumors. In: Tracy TM, Otway M, editors. Clinical ocular oncology. New York: Churchill Livingston; 1989. p. 102.
6.
Beadsmoore CJ, Screaton NJ. Classification, staging and prognosis of lung cancer. Eur J Radiol 2003;45:8–17.PubMedCrossRef
7.
American Thoracic Society/European Respiratory Society. Pretreatment evaluation of non-small cell lung cancer. Am J Respir Crit Care Med 1997;156:320–32.
8.
Skarin A. Respiratory tract and head and neck cancer. In: Rubenstein E, Federman D, editors. Scientific American medicine, vol. 4. Scientific American Inc.; 1995. p. 1–35.
9.
Tsina EK, et al. Treatment of metastatic tumors of the choroid with proton beam irradiation. Ophthalmology 2005;112:337–43.PubMedCrossRef
10.
Nelson CC, Hertzberg BS, Klintworth GK. A histopathologic study of 716 unselected eyes in patients with cancer at the time of death. Am J Ophthalmol 1983;95:788–93.PubMedCrossRef
11.
Ferry AP, Font RL. Carcinoma metastatic to the eye and orbit. I. A clinicopathologic study of 227 cases. Arch Ophthalmol 1974;92:276–86.PubMed
12.
Shields JA, Shields CL. Intraocular tumors: a text and atlas. Philadelphia: WB, Saunders 1992. p. 117–36.
13.
Minatel E, Trovo MG, Forner L, et al. The efficacy of radiotherapy in the treatment of intraocular metastases. Br J Radiol 1993;66:699–702.PubMedCrossRef
14.
Wiegel T, et al. German cancer society. External beam radiotherapy of choroidal metastases-final results of a prospective study of the German Cancer Society (ARO 95-08). Radiother Oncol 2002;64:13–8.PubMedCrossRef
15.
Rosset A, Zografos L, Coucke P, Monney M, Mirimanoff RO. Radiotherapy of choroidal metastases. Radiother Oncol 1998;46:263–8.PubMedCrossRef
Metadata
Title
Choroidal mass as an initial presentation of lung cancer
Authors
Tulay Simsek
Yasemin Ozdamar
Nilufer Berker
Publication date
01-12-2008
Publisher
Humana Press Inc
Published in
Medical Oncology / Issue 4/2008
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-008-9053-3

Other articles of this Issue 4/2008

Medical Oncology 4/2008 Go to the issue

Original Paper

Quality of life one year after chemoradiotherapy for localized primary gastric diffuse large B-cell lymphoma

Letter to the Editor

Management of hypothyroidism after radiotherapy for nasopharyngeal carcinoma

Original Paper

Circulating levels of vascular endothelial growth factor (VEGF), matrix metalloproteinase-3 (MMP-3), and BCL-2 in malignant melanoma

Original Paper

Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis

Original Paper

Matrilysin inhibits proliferation and modulates sensitivity of lung cancer cells to FasL-mediated apoptosis

Original Paper

Multiple myeloma emerging after chemotherapy for non-small-cell lung cancer

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits